MIAMI (PRWEB) October 27, 2015
The Regenestem group of companies (http://www.regenestem.com) has experienced tremendous growth by promoting the latest adult stem cell treatments throughout Latin America and worldwide, and by providing cutting-edge training programs in regenerative medicine for physicians and other healthcare professionals. Therefore, it seemed only natural that Regenestem would offer its providers the opportunity to obtain membership and board certification through its new partner, the American Academy and Board of Regenerative Medicine (AABRM).
As an industry sponsor and partner with AABRM (http://www.aabrm.org), Regenestem will help to build awareness for the Academy and create the highest standard of care among physicians in Latin America and around the world via its Regenestem Network (http://www.regenestemnetwork.com).
The 2015 AABRM Board Certification Course will be held Dec. 5-6 in Golden, Colo. The two-day program will be led by the founding members of the Academy: Joseph Purita, M.D., Terry Grossman, M.D., David Harrell, Ph.D., and Dr. med. Christian Paulus.
Participants who successfully complete the course and meet all AABRM prerequisites will become board certified in regenerative medicine.
"It is an honor and a privilege to be associated with such a great organization that has true visionaries in regenerative medicine as these founding members of the Academy,” said Ricardo De Cubas, founder and CEO of Regenestem. “These gentlemen are real pioneers in their field – and we look forward to helping spread the word about the fine work of the Academy to as many physicians as possible.”
According to De Cubas, the primary objective of this affiliation is to provide Regenestem Network physicians with broad access to the latest science, research, and education in the regenerative medicine field. De Cubas is confident that this collaboration will lead to improved patient outcomes in our network.
"Regenerative medicine is the treatment of the future, that is available today - and the more knowledgeable practitioners are, the better it will be for their practice and their patients," said Dr. Paulus, secretary/treasurer of the Academy. “Regenestem Network has a solid foothold in the industry - so we are confident they can assist us in increasing awareness of the Academy and the promise of adult stem cell therapies around the world.”
About Regenestem and Regenestem Network
Regenestem (http://www.regenestem.com) is an international medical practice company focused on providing comprehensive solutions involving adult stem cell treatments and research. The company has assembled a talented staff of medical specialists - professionals trained in the latest cutting-edge procedures and protocols in cellular medicine. Regenestem is certified for the medical tourism market, and staff physicians are board certified or board-eligible, providing services in more than 10 specialties. Regenestem investigates, shares, utilizes and integrates the latest protocols in the adult stem cell arena to deliver the best medical solutions to its patients.
Regenestem Network (http://www.regenestemnetwork.com) is the largest membership association of regenerative medicine clinics in the world, providing cutting-edge care with the latest advancements in cellular therapies to patients around the world. Regenestem Network is expanding its clinical presence worldwide by partnering with experienced and qualified regenerative medicine physicians to open new clinics licensed and developed under the Regenestem banner.
The American Academy and Board of Regenerative Medicine (http://www.aabrm.org) is a multidisciplinary community of physicians, scientists and industry professionals with a mission to advance the science, technology and practice of regenerative medicine to treat disease and lessen human suffering. The Academy is designed to advance the area of regenerative medicine and provide certifications and standards within this medical specialty. Founded in 2014, AABRM is the leader in setting standards and promoting excellence in the field of regenerative medicine through related educational opportunities, research and publications.